chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Sinusitis, Upper-airway cough syndrome
Clinical narrative: post nasal drip; Headache that comes and goes; 105 Fever; Has taste of pennies in his mouth; Lost sense of taste; Sinuses burned very badly all day like he had salt in his sinuses; Arm swelled up; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelled up), SINUSITIS (Sinuses burned very badly all day like he had salt in his sinuses), PYREXIA (105 Fever), HEADACHE (Headache that comes and goes) and DYSGEUSIA (Has taste of pennies in his mouth) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0388821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced PERIPHERAL SWELLING (Arm swelled up). On 12-Apr-2021, the patient experienced SINUSITIS (Sinuses burned very badly all day like he had salt in his sinuses). On 19-Apr-2021, the patient experienced PYREXIA (105 Fever), HEADACHE (Headache that comes and goes), DYSGEUSIA (Has taste of pennies in his mouth) and AGEUSIA (Lost sense of taste). On an unknown date, the patient experienced UPPER-AIRWAY COUGH SYNDROME (post nasal drip). On 19-Apr-2021, PYREXIA (105 Fever) had resolved. At the time of the report, PERIPHERAL SWELLING (Arm swelled up), HEADACHE (Headache that comes and goes), DYSGEUSIA (Has taste of pennies in his mouth), AGEUSIA (Lost sense of taste) and UPPER-AIRWAY COUGH SYNDROME (post nasal drip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was mentioned. No treatment medication was mentioned.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Flushing, Hypoaesthesia, Influenza like illness, Paraesthesia
Clinical narrative: Flushing; felt like I had the flu; I had 101.8 fever; Numbness and tingling in my mouth, neck, throat; Numbness and tingling in my mouth, neck, throat / Pin prick sensations going up my arms; This spontaneous case was reported by a patient and describes the occurrence of HYPOAESTHESIA (Numbness and tingling in my mouth, neck, throat), PARAESTHESIA (Numbness and tingling in my mouth, neck, throat / Pin prick sensations going up my arms), FLUSHING (Flushing), INFLUENZA LIKE ILLNESS (felt like I had the flu) and PYREXIA (I had 101.8 fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 025J20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included HCTZ, PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) and ESTRADIOL (VIVELLE [ESTRADIOL]) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness and tingling in my mouth, neck, throat) and PARAESTHESIA (Numbness and tingling in my mouth, neck, throat / Pin prick sensations going up my arms). On 12-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like I had the flu) and PYREXIA (I had 101.8 fever). On an unknown date, the patient experienced FLUSHING (Flushing). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 25 mg. On 14-Feb-2021, HYPOAESTHESIA (Numbness and tingling in my mouth, neck, throat), PARAESTHESIA (Numbness and tingling in my mouth, neck, throat / Pin prick sensations going up my arms), INFLUENZA LIKE ILLNESS (felt like I had the flu) and PYREXIA (I had 101.8 fever) had resolved. At the time of the report, FLUSHING (Flushing) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Body temperature: 101.8 (High) 101.8 Fever.         This case was linked to MOD-2021-021154 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Flushing; felt like I had the flu; I had 101.8 fever; Numbness and tingling in my mouth, neck, throat; Numbness and tingling in my mouth, neck, throat / Pin prick sensations going up my arms; This spontaneous case was reported by a patient and describes the occurrence of HYPOAESTHESIA (Numbness and tingling in my mouth, neck, throat), PARAESTHESIA (Numbness and tingling in my mouth, neck, throat / Pin prick sensations going up my arms), FLUSHING (Flushing), INFLUENZA LIKE ILLNESS (felt like I had the flu) and PYREXIA (I had 101.8 fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 025J20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included HCTZ, PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) and ESTRADIOL (VIVELLE [ESTRADIOL]) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness and tingling in my mouth, neck, throat) and PARAESTHESIA (Numbness and tingling in my mouth, neck, throat / Pin prick sensations going up my arms). On 12-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like I had the flu) and PYREXIA (I had 101.8 fever). On an unknown date, the patient experienced FLUSHING (Flushing). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 25 mg. On 14-Feb-2021, HYPOAESTHESIA (Numbness and tingling in my mouth, neck, throat), PARAESTHESIA (Numbness and tingling in my mouth, neck, throat / Pin prick sensations going up my arms), INFLUENZA LIKE ILLNESS (felt like I had the flu) and PYREXIA (I had 101.8 fever) had resolved. At the time of the report, FLUSHING (Flushing) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Body temperature: 101.8 (High) 101.8 Fever.         This case was linked to MOD-2021-021154 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Nasopharyngitis, Sinus disorder, Vision blurred
Clinical narrative: sinuses; Vision is blurry / Don't seem to be getting better; Utterly exhausted; came down with what I thought was a cold /Cold getting worse; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (came down with what I thought was a cold /Cold getting worse), SINUS DISORDER (sinuses), VISION BLURRED (Vision is blurry / Don't seem to be getting better) and FATIGUE (Utterly exhausted) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced NASOPHARYNGITIS (came down with what I thought was a cold /Cold getting worse). On an unknown date, the patient experienced SINUS DISORDER (sinuses), VISION BLURRED (Vision is blurry / Don't seem to be getting better) and FATIGUE (Utterly exhausted). At the time of the report, NASOPHARYNGITIS (came down with what I thought was a cold /Cold getting worse) and VISION BLURRED (Vision is blurry / Don't seem to be getting better) had not resolved, SINUS DISORDER (sinuses) was resolving and FATIGUE (Utterly exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Vision blurred
Clinical narrative: Left eye will track off, get blurry and won't focus on and off; had little tempreture .still feels warm like he has a fever but he doesn't actually have a fever; Arm swelled up; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelled up), VISION BLURRED (Left eye will track off, get blurry and won't focus on and off) and PYREXIA (had little tempreture .still feels warm like he has a fever but he doesn't actually have a fever) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 0388821A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced PERIPHERAL SWELLING (Arm swelled up) and PYREXIA (had little tempreture .still feels warm like he has a fever but he doesn't actually have a fever). On 18-Jun-2021, the patient experienced VISION BLURRED (Left eye will track off, get blurry and won't focus on and off). At the time of the report, PERIPHERAL SWELLING (Arm swelled up), VISION BLURRED (Left eye will track off, get blurry and won't focus on and off) and PYREXIA (had little tempreture .still feels warm like he has a fever but he doesn't actually have a fever) outcome was unknown.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Feeling hot, Headache, Hot flush
Clinical narrative: got very ill after vaccination; brain fog; hot flash/ sweats/ feeling hot; Feeling hot; hot flush; Headache; body ache; Tired; Nauseas; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (got very ill after vaccination), FEELING ABNORMAL (brain fog), HYPERHIDROSIS (hot flash/ sweats/ feeling hot), FEELING HOT (Feeling hot) and HOT FLUSH (hot flush) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048CZ1A and 048CZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CARBIDOPA, LEVODOPA (LEVODOPA/CARBIDOPA), ASPIRIN [ACETYLSALICYLIC ACID], AMLODIPINE, ONDANSETRON and TESTOSTERONE for an unknown indication.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Jun-2021, the patient experienced FEELING ABNORMAL (brain fog), HYPERHIDROSIS (hot flash/ sweats/ feeling hot), FEELING HOT (Feeling hot), HOT FLUSH (hot flush), HEADACHE (Headache), MYALGIA (body ache), FATIGUE (Tired) and NAUSEA (Nauseas). On an unknown date, the patient experienced VACCINATION COMPLICATION (got very ill after vaccination). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, VACCINATION COMPLICATION (got very ill after vaccination), FEELING ABNORMAL (brain fog), HYPERHIDROSIS (hot flash/ sweats/ feeling hot), FEELING HOT (Feeling hot), HOT FLUSH (hot flush), HEADACHE (Headache), MYALGIA (body ache), FATIGUE (Tired) and NAUSEA (Nauseas) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Historical condition include the tendency to dry out due to Hypomcigremia. Concomitant product used acid reflux medication.   This case was linked to MOD-2021-110171 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Myalgia, Nausea, Vaccination complication
Clinical narrative: got very ill after vaccination; brain fog; hot flash/ sweats/ feeling hot; Feeling hot; hot flush; Headache; body ache; Tired; Nauseas; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (got very ill after vaccination), FEELING ABNORMAL (brain fog), HYPERHIDROSIS (hot flash/ sweats/ feeling hot), FEELING HOT (Feeling hot) and HOT FLUSH (hot flush) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048CZ1A and 048CZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CARBIDOPA, LEVODOPA (LEVODOPA/CARBIDOPA), ASPIRIN [ACETYLSALICYLIC ACID], AMLODIPINE, ONDANSETRON and TESTOSTERONE for an unknown indication.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Jun-2021, the patient experienced FEELING ABNORMAL (brain fog), HYPERHIDROSIS (hot flash/ sweats/ feeling hot), FEELING HOT (Feeling hot), HOT FLUSH (hot flush), HEADACHE (Headache), MYALGIA (body ache), FATIGUE (Tired) and NAUSEA (Nauseas). On an unknown date, the patient experienced VACCINATION COMPLICATION (got very ill after vaccination). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, VACCINATION COMPLICATION (got very ill after vaccination), FEELING ABNORMAL (brain fog), HYPERHIDROSIS (hot flash/ sweats/ feeling hot), FEELING HOT (Feeling hot), HOT FLUSH (hot flush), HEADACHE (Headache), MYALGIA (body ache), FATIGUE (Tired) and NAUSEA (Nauseas) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Historical condition include the tendency to dry out due to Hypomcigremia. Concomitant product used acid reflux medication.   This case was linked to MOD-2021-110171 (Patient Link).
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Vaccine leaked out of syringe during administration; Vaccine leaked out of syringe during administration; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Vaccine leaked out of syringe during administration) and DEVICE CONNECTION ISSUE (Vaccine leaked out of syringe during administration) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, the patient experienced UNDERDOSE (Vaccine leaked out of syringe during administration) and DEVICE CONNECTION ISSUE (Vaccine leaked out of syringe during administration). At the time of the report, UNDERDOSE (Vaccine leaked out of syringe during administration) and DEVICE CONNECTION ISSUE (Vaccine leaked out of syringe during administration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant Concomitant medications were reported.  No Treatment Information Provided.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration of Expired Vaccine; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine). On 08-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter.  No treatment medication was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: minor experience I had. It was a very brief and short lived. My minor events could have been due to other environmental factors.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (minor experience I had. It was a very brief and short lived. My minor events could have been due to other environmental factors.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (minor experience I had. It was a very brief and short lived. My minor events could have been due to other environmental factors.). At the time of the report, VACCINATION COMPLICATION (minor experience I had. It was a very brief and short lived. My minor events could have been due to other environmental factors.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported No treatment medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: I had severe muscle cramping in my legs last night; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE SPASMS (I had severe muscle cramping in my legs last night) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (I had severe muscle cramping in my legs last night). At the time of the report, MUSCLE SPASMS (I had severe muscle cramping in my legs last night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Hypoaesthesia, Musculoskeletal stiffness, Pain, Pain in extremity
Clinical narrative: extreme soreness; minor swelling; stiffness; It's debilitating my ability to earn money and pay bills; Bilateral pain in arms; Numbness in both arms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (extreme soreness), SWELLING (minor swelling), MUSCULOSKELETAL STIFFNESS (stiffness), ASTHENIA (It's debilitating my ability to earn money and pay bills) and PAIN IN EXTREMITY (Bilateral pain in arms) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Bilateral pain in arms) and HYPOAESTHESIA (Numbness in both arms). On an unknown date, the patient experienced PAIN (extreme soreness), SWELLING (minor swelling), MUSCULOSKELETAL STIFFNESS (stiffness) and ASTHENIA (It's debilitating my ability to earn money and pay bills). At the time of the report, PAIN (extreme soreness), SWELLING (minor swelling), MUSCULOSKELETAL STIFFNESS (stiffness), PAIN IN EXTREMITY (Bilateral pain in arms) and HYPOAESTHESIA (Numbness in both arms) had not resolved and ASTHENIA (It's debilitating my ability to earn money and pay bills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication also included other vitamins. No treatment medications were reported.  She was having an electrogram and nerve procedure done this week. Patient saw physician in April for severe pain and numbness.   This case was linked to MOD-2021-237947 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Significant follow up received on 06-AUG-2021.  added Containing Event added (Debility, pain in arms and Numbness of upper arms)
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: extreme soreness; minor swelling; stiffness; It's debilitating my ability to earn money and pay bills; Bilateral pain in arms; Numbness in both arms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (extreme soreness), SWELLING (minor swelling), MUSCULOSKELETAL STIFFNESS (stiffness), ASTHENIA (It's debilitating my ability to earn money and pay bills) and PAIN IN EXTREMITY (Bilateral pain in arms) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Bilateral pain in arms) and HYPOAESTHESIA (Numbness in both arms). On an unknown date, the patient experienced PAIN (extreme soreness), SWELLING (minor swelling), MUSCULOSKELETAL STIFFNESS (stiffness) and ASTHENIA (It's debilitating my ability to earn money and pay bills). At the time of the report, PAIN (extreme soreness), SWELLING (minor swelling), MUSCULOSKELETAL STIFFNESS (stiffness), PAIN IN EXTREMITY (Bilateral pain in arms) and HYPOAESTHESIA (Numbness in both arms) had not resolved and ASTHENIA (It's debilitating my ability to earn money and pay bills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication also included other vitamins. No treatment medications were reported.  She was having an electrogram and nerve procedure done this week. Patient saw physician in April for severe pain and numbness.   This case was linked to MOD-2021-237947 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Significant follow up received on 06-AUG-2021.  added Containing Event added (Debility, pain in arms and Numbness of upper arms)
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Swelling
Clinical narrative: Swelling at collar bone; lymph node symptoms near collar bone; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling at collar bone) and LYMPHADENOPATHY (lymph node symptoms near collar bone) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling at collar bone) and LYMPHADENOPATHY (lymph node symptoms near collar bone). At the time of the report, SWELLING (Swelling at collar bone) and LYMPHADENOPATHY (lymph node symptoms near collar bone) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. List of concomitant medication were not given.   This case was linked to MOD-2021-074208, MOD-2021-074228 (Patient Link).   Reporter did not allow further contact
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Extra dose administered, Myalgia
Clinical narrative: 3rd dose of the COVID-19 vaccine on 13APR2021 and the 4th dose on 10MAY2021; mildly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (3rd dose of the COVID-19 vaccine on 13APR2021 and the 4th dose on 10MAY2021) and MYALGIA (mildly sore arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder NOS (Blood condition). Concomitant products included ATORVASTATIN, MAGNESIUM OXIDE, FISH OIL, MINERALS NOS, VITAMINS NOS (CENTRUM JR [MINERALS NOS;VITAMINS NOS]), PANTOPRAZOLE, FINASTERIDE, TAMSULOSIN, AMLODIPINE, FERROUS SULFATE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (mildly sore arm). On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (3rd dose of the COVID-19 vaccine on 13APR2021 and the 4th dose on 10MAY2021). On 12-Feb-2021, MYALGIA (mildly sore arm) had resolved. At the time of the report, EXTRA DOSE ADMINISTERED (3rd dose of the COVID-19 vaccine on 13APR2021 and the 4th dose on 10MAY2021) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Antibody test: negative (Negative) Spike protein antibody test was negative on Mar-2021.. In June 2021, Antibody test: negative (Negative) Spike protein antibody test was negative on Jun-2021..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided.   This case was linked to MOD-2021-237330, MOD-2021-238101 (Patient Link).
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Pain in extremity, SARS-CoV-2 antibody test
Clinical narrative: mildly sore left arm; mildly sore left arm; received 4 shots of the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (received 4 shots of the Moderna vaccine), the first episode of PAIN IN EXTREMITY (mildly sore left arm) and the second episode of PAIN IN EXTREMITY (mildly sore left arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A, 036B21A, 030M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder (Autoimmune Blood Disorder). Concomitant products included ATORVASTATIN, MAGNESIUM OXIDE, FISH OIL, CENTRUM VITAMINTS, PANTOPRAZOLE, FINASTERIDE, TAMSULOSIN, AMLODIPINE, FERROUS SULFATE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 13-Apr-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 3 dosage form. On 10-May-2021, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 4 dosage form. On 12-Jan-2021, the patient experienced EXTRA DOSE ADMINISTERED (received 4 shots of the Moderna vaccine). On 15-Apr-2021, the patient experienced the first episode of PAIN IN EXTREMITY (mildly sore left arm). On 12-May-2021, the patient experienced the second episode of PAIN IN EXTREMITY (mildly sore left arm). On 10-May-2021, EXTRA DOSE ADMINISTERED (received 4 shots of the Moderna vaccine) outcome was unknown. On 13-May-2021, last episode of PAIN IN EXTREMITY (mildly sore left arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, SARS-CoV-2 antibody test: others (Negative) negative. In June 2021, SARS-CoV-2 antibody test: others (Negative) negative.         This case was linked to MOD-2021-237330, MOD-2021-238058 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Alternative contact number updated and patient demographics added.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: after the second shot she ran a Fever 101.4 Fahrenheit.; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (after the second shot she ran a Fever 101.4 Fahrenheit.) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (after the second shot she ran a Fever 101.4 Fahrenheit.). On 16-Apr-2021, PYREXIA (after the second shot she ran a Fever 101.4 Fahrenheit.) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4 (High) 12 hours after the second shot she ran a Fever 101.4 Fahrenheit..         No concomitant medication was reported. No treatment was reported.    This case was linked to MOD-2021-059782 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site discomfort
Clinical narrative: mild injection site discomfort; mild fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (mild injection site discomfort) and FATIGUE (mild fatigue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOMFORT (mild injection site discomfort) and FATIGUE (mild fatigue). At the time of the report, VACCINATION SITE DISCOMFORT (mild injection site discomfort) and FATIGUE (mild fatigue) outcome was unknown.            No Concomitant medications were reported No Treatment information was reported.   This case was linked to MOD-2021-008700 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Myalgia, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of erythema (red arm), pyrexia and myalgia (sore arms) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced erythema (red arm), pyrexia and myalgia (sore arms). At the time of the report, erythema (red arm), pyrexia and myalgia (sore arms) outcome: unknown. Concomitant medication include blood pressure and pain medication for unknown indication. No treatment medication reported. This case linked to MOD-2021-046513 (patient link).
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Rash, Urticaria
Clinical narrative: bad reaction; bumps all over; bad reaction with rashes; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INJECTION SITE REACTION (bad reaction), URTICARIA (bumps all over) and RASH (bad reaction with rashes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     no medical history was reported by reporter.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE REACTION (bad reaction), URTICARIA (bumps all over) and RASH (bad reaction with rashes). At the time of the report, INJECTION SITE REACTION (bad reaction), URTICARIA (bumps all over) and RASH (bad reaction with rashes) outcome was unknown.            no concomitant and treatment medications are provided.
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: sickness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sickness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included Kidney transplant and Cancer. Concomitant products included TACROLIMUS for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sickness). At the time of the report, ILLNESS (sickness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided.
Sex: U
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Kidney transplant. Concurrent medical conditions included Cancer. Concomitant products included TACROLIMUS for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.            No concomitant medication history were reported No treatment medication information were reported
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Pain
Clinical narrative: Sore Throat; Body aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat), PAIN (Body aches) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included APIXABAN (ELIQUIS), ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION), PARACETAMOL (TYLENOL), POTASSIUM CHLORIDE (KLOR-CON), TRAMADOL, CITALOPRAM, FUROSEMIDE, GABAPENTIN, LISINOPRIL and LORAZEPAM for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore Throat), PAIN (Body aches) and HEADACHE (Headache). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat), PAIN (Body aches) and HEADACHE (Headache) had resolved.            No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Got hit the 2nd day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Got hit the 2nd day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Got hit the 2nd day). At the time of the report, VACCINATION COMPLICATION (Got hit the 2nd day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-238346 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.            No Concomitant medication was provided.  The patient reported that after the second vaccine dose she developed a rash that was on the same arm but on the opposite side of the injection site. The rash was very hot and approximately 5 by 3.5 inches large. The patient has applied a cold compress, which has helped. The patient reported that after her first vaccine dose she had experienced a slight headache for approximately 10 hours.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: gave vaccine way below deltoid; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (gave vaccine way below deltoid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (gave vaccine way below deltoid). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (gave vaccine way below deltoid) outcome was unknown.            Concomitant medication not provided by reporter.  Treatment information not provided by reporter
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Nodule
Clinical narrative: She presented with a firm nodule along her right peroorbital rim; Having a reaction; This spontaneous case was reported by a physician and describes the occurrence of INJECTION SITE REACTION (Having a reaction) and NODULE (She presented with a firm nodule along her right peroorbital rim) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product BOTULINUM TOXIN TYPE A HAEMAGGLUTININ COMPLEX (DYSPORT) injection for an unknown indication.    No Medical History information was reported.   On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-May-2021, the patient started BOTULINUM TOXIN TYPE A HAEMAGGLUTININ COMPLEX (DYSPORT) (unknown route) 150 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced INJECTION SITE REACTION (Having a reaction). On an unknown date, the patient experienced NODULE (She presented with a firm nodule along her right peroorbital rim). The patient was treated with VORHYALURONIDASE ALFA (HYLENEX) for Adverse event, at a dose of UNK dosage form. At the time of the report, INJECTION SITE REACTION (Having a reaction) and NODULE (She presented with a firm nodule along her right peroorbital rim) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided. It was reported that patient had Dysport injected in her glabella, forehead, and crow's feet. The Dysport was reconstituted with 1.25 ml of bacteriostatic normal saline, was stored in a temperature controlled refrigerator before and after injection, and was used within one hour of dilution. The patient was not pre-medicated prior to the injection. Patient wanted to see the doctor. Patient had a nodule on the area where she had previously had filler. On an unknown date in Nov 2020, patient had Restylane Lyft, a full syringe, injected in the left temple. Restylane 0.2 cc was also injected in tear troughs on both sides in Nov 2020. In Oct 2020, patient had Versa 1.2 cc injected superficially via cannula in each temple. In Jan 2021, an unknown filler was injected in lower face by another provider, as reported to HCP by patient. HCP viewed it as a delayed inflammatory nodule, injected treatment and advised her to massage it. On 21 May 2021, HCP gave her a touch up of Dysport as well, as she needed a little touch up in her crow's feet and forehead.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test negative, SARS-CoV-2 antibody test negative
Clinical narrative: antibody screening test findings zero antibodies; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (antibody screening test findings zero antibodies) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (antibody screening test findings zero antibodies). At the time of the report, ANTIBODY TEST NEGATIVE (antibody screening test findings zero antibodies) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test negative: negative negative (Negative) negative.         Action taken with mRNA-1273 in response to the events was not applicable.  Concomitant medication was not provided.  Treatment medication was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: Arm started to hurt; Chills; High temperature; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm started to hurt), CHILLS (Chills) and PYREXIA (High temperature) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 032B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (Allergy: PCN), Sulfonamide allergy (Allergy: Sulfa), Drug allergy (Allergy: Aleve) and Crohn's disease since 31-May-1999. Concomitant products included ADALIMUMAB (HUMIRA) for Crohn's disease.   On 05-Apr-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021 at 8:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced PAIN IN EXTREMITY (Arm started to hurt), CHILLS (Chills) and PYREXIA (High temperature). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 06-May-2021, PAIN IN EXTREMITY (Arm started to hurt) and CHILLS (Chills) had resolved. At the time of the report, PYREXIA (High temperature) had resolved.            The action taken with mRNA-1273 was not applicable.   This case was linked to MOD-2021-068520 (Patient Link).
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cyst, Pain in extremity, Pyrexia
Clinical narrative: cyst; leg pain; pain in arm; fever; pain ankle; chills; This spontaneous case was reported by an other and describes the occurrence of CYST (cyst), PAIN IN EXTREMITY (leg pain), PAIN IN EXTREMITY (pain in arm), PYREXIA (fever) and ARTHRALGIA (pain ankle) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Ulcerative colitis and Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 UNK. On an unknown date, the patient experienced CYST (cyst), PAIN IN EXTREMITY (leg pain), PAIN IN EXTREMITY (pain in arm), PYREXIA (fever), ARTHRALGIA (pain ankle) and CHILLS (chills). At the time of the report, CYST (cyst), PAIN IN EXTREMITY (leg pain) and ARTHRALGIA (pain ankle) had not resolved and PAIN IN EXTREMITY (pain in arm), PYREXIA (fever) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       An ultrasound was done on an unknown date. Treatment was not reported.